Orion stock reports EUR 8,666,359.16 in weekly buybacks

Published on 09/25/2026 at 13:33 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Orion stock traded at EUR 82.85 on September 25, 2026, 1.49 percent below its 52-week high. Market capitalization was EUR 11.66 billion, while 107,674 shares were repurchased.

Isometrische Grafik der Pharma-Produktionskette, Orion Oyj FI0009014377 — Isometrische 3D-Illustration zeigt Wertschöpfungskette der Pharmaproduktion von Orion Oyj, ISIN FI0009014377, schematisch, Illustration mit AI erstellt.

Orion stock (FI0009014377) traded at EUR 82.85 on Nasdaq Helsinki on September 25, 2026, down EUR 0.05 or 0.06 percent from the previous close. The pharmaceutical company repurchased 107,674 B shares for EUR 8,666,359.16 during the week ended September 18, according to GlobeNewswire on September 18, 2026.

Weekly repurchases reach EUR 8.7 million

The buyback covered five trading sessions from September 14 through September 18. Orion paid an average EUR 80.4870 per share, while the September 18 purchases averaged EUR 81.9661 and totaled EUR 1,716,206.20.

The company held 616,646 treasury shares after the transactions, all Class B shares. The program began on September 1, 2026, and runs through December 31, 2026, or an earlier date if the authorized amount is completed.

Stock stays near its yearly high

At 2:28 p.m. EEST on September 25, 2026, Orion stock stood 1.49 percent below its 52-week high of EUR 84.10 and 46.64 percent above its 52-week low of EUR 56.50. The quoted market capitalization was EUR 11,660,537,832, with 22,225 shares traded.

The price comparison gives the buyback context a clear market test: the weekly average purchase price of EUR 80.4870 was EUR 2.3630 below the September 25 intraday quote. That difference equals 2.94 percent, leaving the company repurchasing shares below the latest quoted level.

Half-year date anchors the next checkpoint

Orion's investor relations page lists the Half-Year Financial Report for January through June 2026 as published on July 17, 2026, and presents the company as a pharmaceutical group focused on innovative medicines and a diversified product portfolio. The company reported historical 2025 net sales of EUR 1,890 million and employment of 4,000 professionals in the September 18 release.

The share program therefore supplies the immediate company-specific event, while the September 25 quote places the stock close to its annual peak. For investors, the key measurable signals are the EUR 8,666,359.16 weekly allocation, the EUR 80.4870 average purchase price and the EUR 82.85 market quote.

Orion stock trades at EUR 82.85

Orion stock was trading at EUR 82.85 on Nasdaq Helsinki at 2:28 p.m. EEST on September 25, 2026. The intraday change was minus 0.06 percent from EUR 82.90.